News & AnalysisMinervaX attracts $57m Series BMinervaX, a Danish biotechnology company, has raised $57 million in Series B financing.ByIris Dorbian16 December 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareTechnologyBriefs